Sage Rhino Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-7,022
| Closed | -$202K | – | 244 |
|
|
2023
Q4 | $202K | Buy |
7,022
+60
| +0.9% | +$1.73K | 0.05% | 204 |
|
|
2023
Q3 | $231K | Sell |
6,962
-696
| -9% | -$23.1K | 0.06% | 183 |
|
|
2023
Q2 | $281K | Sell |
7,658
-651
| -8% | -$23.9K | 0.08% | 168 |
|
|
2023
Q1 | $339K | Buy |
8,309
+361
| +5% | +$14.7K | 0.1% | 148 |
|
|
2022
Q4 | $407K | Buy |
7,948
+119
| +2% | +$6.1K | 0.13% | 124 |
|
|
2022
Q3 | $343K | Sell |
7,829
-309
| -4% | -$13.5K | 0.14% | 116 |
|
|
2022
Q2 | $427K | Buy |
8,138
+146
| +2% | +$7.66K | 0.16% | 104 |
|
|
2022
Q1 | $414K | Buy |
7,992
+122
| +2% | +$6.32K | 0.13% | 138 |
|
|
2021
Q4 | $465K | Buy |
7,870
+168
| +2% | +$9.93K | 0.13% | 128 |
|
|
2021
Q3 | $331K | Sell |
7,702
-58
| -0.7% | -$2.49K | 0.1% | 144 |
|
|
2021
Q2 | $304K | Buy |
7,760
+204
| +3% | +$7.99K | 0.09% | 151 |
|
|
2021
Q1 | $274K | Sell |
7,556
-11
| -0.1% | -$399 | 0.09% | 143 |
|
|
2020
Q4 | $279K | Sell |
7,567
-287
| -4% | -$10.6K | 0.11% | 136 |
|
|
2020
Q3 | $273K | Sell |
7,854
-25
| -0.3% | -$869 | 0.13% | 123 |
|
|
2020
Q2 | $244K | Buy |
7,879
+234
| +3% | +$7.25K | 0.13% | 127 |
|
|
2020
Q1 | $237K | Sell |
7,645
-1,943
| -20% | -$60.2K | 0.17% | 107 |
|
|
2019
Q4 | $359K | Buy |
9,588
+742
| +8% | +$27.8K | 0.2% | 102 |
|
|
2019
Q3 | $302K | Sell |
8,846
-756
| -8% | -$25.8K | 0.19% | 102 |
|
|
2019
Q2 | $395K | Sell |
9,602
-135
| -1% | -$5.55K | 0.25% | 84 |
|
|
2019
Q1 | $392K | Buy |
+9,737
| New | +$392K | 0.26% | 81 |
|